BG Medicine has tapped Paul Sohmer to be president, CEO, and a member of its board of directors, effective immediately, the company said this week. He replaces Eric Bouvier, who will remain with the company as a consultant.
Sohmer previously was CEO of several medical device and diagnostics companies, including Pathway Diagnostics, Viracor-IBT Laboratories, and Orthocon, and he was chairman, president, and CEO of TriPath Imaging before it was acquired by Becton Dickinson.
Early in his career, Sohmer also was CEO of Genetrix, a genetic testing lab that was acquired by Genzyme.
Danaher has re-elected seven directors to continue serving on the board until their terms expire in 2014, including Steven Rales, Donald Ehrlich, Linda Hefner Filler, Teri List-Stoll, Walter Lohr, John Schwieters, and Alan Spoon.
Provista Diagnsotics' stockholders have re-elected the members of its board of directors, including Anne Busquet, Jeffrey Gilman, Robert Hariri, Jack Levine, John Macaskill, David Reese, and John Zicarelli.